Galvez: About 2 million people in PH to be vaccinated by April | Inquirer News
Close  

Galvez: About 2 million people in PH to be vaccinated by April

By: - Reporter / @DYGalvezINQ
/ 04:10 PM January 11, 2021
Presidential Peace Adviser Carlito Galvez Jr.

Presidential Peace adviser and concurrent National Task Force COVID-19 Response Chief Implementor Carlito Galvez Jr. FILE PHOTO

MANILA, Philippines — About two million people in the Philippines could be vaccinated against the coronavirus disease 2019 (COVID-19) by April this year, vaccine czar Gen. Carlito Galvez Jr. said Monday.

During a Senate inquiry on the government’s COVID-19 vaccination program, Galvez said 50,000 doses of a COVID-19 vaccine is expected to arrive in the country in February.

ADVERTISEMENT

An additional 950,000 vaccine doses will also arrive in the country by March and another one million doses will arrive by April.

“Sa April po, ang mababakunahan ay more or less almost two million,” Galvez said. (So by the month April, more or less two million people will be vaccinated.)

FEATURED STORIES

He did not name which brand of COVID-19 vaccine will be the first to arrive but it will most likely come from Pfizer-BioNTech and Sinovac.

The government will also prioritize vaccinating people in Metro Manila, as well as Cebu City and Davao City, where the COVID-19 attack rate is high.

The Philippine government is eyeing to secure about 144 million doses of COVID-19 vaccines this year, Galvez said.

The Philippines has so far secured 30 million doses of a COVID-19 vaccine and may secure 60 million more this week.

JPV
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: 2 million people, April, COVID-19 Vaccine, Galvez, vaccine czar
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.